Alessandri, Giulio
 Distribuzione geografica
Continente #
NA - Nord America 242
EU - Europa 226
AS - Asia 43
SA - Sud America 1
Totale 512
Nazione #
US - Stati Uniti d'America 240
PL - Polonia 135
IT - Italia 26
SE - Svezia 25
CN - Cina 22
SG - Singapore 12
FR - Francia 7
IE - Irlanda 7
UA - Ucraina 7
DE - Germania 4
FI - Finlandia 4
ID - Indonesia 4
GB - Regno Unito 3
IN - India 3
AT - Austria 2
CA - Canada 2
RU - Federazione Russa 2
BE - Belgio 1
CL - Cile 1
GR - Grecia 1
HR - Croazia 1
LT - Lituania 1
TR - Turchia 1
VN - Vietnam 1
Totale 512
Città #
Warsaw 135
Chandler 38
Fairfield 30
Houston 17
Ashburn 16
Woodbridge 15
Cattolica 11
Seattle 11
Cambridge 10
Jacksonville 10
Wilmington 10
Ann Arbor 8
Falls Church 8
Dublin 7
Nanjing 7
Singapore 7
Beijing 5
Dearborn 5
Milan 5
Jakarta 4
Lawrence 4
New York 3
San Mateo 3
Boardman 2
Boston 2
Bremen 2
Los Angeles 2
Marseille 2
Moscow 2
Vienna 2
Andover 1
Berlin 1
Brussels 1
Changsha 1
Clearwater 1
Dong Ket 1
Hangzhou 1
Hebei 1
Islington 1
Izmir 1
Jiaxing 1
London 1
Nanchang 1
Ottawa 1
Palermo 1
Paris 1
Phoenix 1
Redmond 1
Rome 1
San Francisco 1
Southend 1
Tianjin 1
Toronto 1
Zagreb 1
Totale 407
Nome #
Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts 324
Fibronectin-adherent peripheral blood derived mononuclear cells as Paclitaxel carriers for glioblastoma treatment: An in vitro study 68
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy 65
Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study 63
Totale 520
Categoria #
all - tutte 1.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.635


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202064 0 0 0 0 4 7 10 8 13 5 12 5
2020/202153 7 9 1 3 10 2 3 0 10 3 4 1
2021/202256 6 5 1 2 6 9 0 5 5 5 5 7
2022/202396 14 12 8 15 5 12 3 12 11 1 3 0
2023/202425 1 9 0 3 0 2 1 0 0 0 4 5
2024/202521 2 3 5 0 11 0 0 0 0 0 0 0
Totale 520